Evaluation of UGT protein interactions in human hepatocytes: Effect of siRNA down regulation of UGT1A9 and UGT2B7 on propofol glucuronidation in human hepatocytes

被引:10
|
作者
Konopnicki, Camille M. [1 ]
Dickmann, Leslie J. [2 ]
Tracy, Jeffrey M. [3 ]
Tukey, Robert H. [1 ]
Wienkers, Larry C. [2 ]
Foti, Robert S. [2 ]
机构
[1] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA
[2] Amgen Inc, Pharmacokinet & Drug Metab, Seattle, WA 98119 USA
[3] Amgen Inc, Inflammat Res, Seattle, WA 98119 USA
关键词
UDP-Glucuronosyltransferase; siRNA; Protein interactions; Hepatocytes; HUMAN UDP-GLUCURONOSYLTRANSFERASES; HUMAN DRUG GLUCURONIDATION; IN-VITRO; METABOLIZING-ENZYMES; LIVER-MICROSOMES; CYTOCHROME-P450; MODULATION; EXPRESSION; HOMODIMERIZATION; INACTIVATION;
D O I
10.1016/j.abb.2013.03.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous experiments performed in recombinant systems have suggested that protein-protein interactions occur between the UGTs and may play a significant role in modulating enzyme activity. However, evidence of UGT protein protein interactions either in vivo or in more physiologically relevant in vitro systems has yet to be demonstrated. In this study, we examined oligomerization and its ability to affect glucuronidation in plated human hepatocytes. siRNA down regulation experiments and activity studies were used to examine changes in metabolite formation of one UGT isoform due to down regulation of a second UGT isoform. Selective siRNA directed towards UGT1A9 or UGT2B7 resulted in significant and selective decreases in their respective mRNA levels. As expected, the metabolism of the UGT1A9 substrate propofol decreased with UGT1A9 down regulation. Interestingly, UGT1A9 activity, but not UGT1A9 mRNA expression, was also diminished when UGT2B7 expression was selectively inhibited, implying potential interactions between the two isoforms. Minor changes to UGT1A4, UGT2B4 and UGT2B7 activity were also observed when UGT1A9 expression was selectively down regulated. To our knowledge, this represents the first piece of evidence that UGT protein-protein interactions occur in human hepatocytes and suggests that expression levels of UGT2B7 may directly impact the glucuronidation activity of selective UGT1A9 substrates. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:143 / 149
页数:7
相关论文
共 50 条
  • [1] Evaluation of UGT Protein Interactions in Human Hepatocytes: Effect of siRNA Down Regulation of UGT1A9 and UGT2B7 on Propofol Glucuronidation
    Foti, Robert S.
    Konopnicki, Camille M.
    Dickmann, Leslie J.
    Tracy, Jeffrey M.
    Tukey, Robert H.
    Wienkers, Larry C.
    FASEB JOURNAL, 2013, 27
  • [2] Glucuronidation of 1′-hydroxyestragole (1′-HE) by human UDP-glucuronosyltransferases UGT2B7 and UGT1A9
    Iyer, LV
    Ho, MN
    Shinn, WM
    Bradford, WW
    Tanga, MJ
    Nath, SS
    Green, CE
    TOXICOLOGICAL SCIENCES, 2003, 73 (01) : 36 - 43
  • [3] In vitro glucuronidation of mycophenolic acid by human UGTs and the impact of known polymorphisms of UGT1A8, UGT1A9, and UGT2B7
    Bernard, O
    Guillemette, C
    DRUG METABOLISM REVIEWS, 2003, 35 : 53 - 53
  • [4] Glucuronidation of catechols by human hepatic, gastric, and intestinal microsomal UDP-glucuronosyltransferases (UGT) and recombinant UGT1A6, UGT1A9, and UGT2B7
    Antonio, L
    Xu, J
    Little, JM
    Burchell, B
    Magdalou, J
    Radominska-Pandya, A
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2003, 411 (02) : 251 - 261
  • [5] Involvement of UDP-Glucuronosyltransferases UGT1A9 and UGT2B7 in Ethanol Glucuronidation, and Interactions with Common Drugs of Abuse
    Al Saabi, Alaa
    Allorge, Delphine
    Sauvage, Francois-Ludovic
    Tournel, Gilles
    Gaulier, Jean-michel
    Marquet, Pierre
    Picard, Nicolas
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (03) : 568 - 574
  • [6] Kinetic characterisation of S-naproxen glucuronidation by human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7
    Knights, KM
    Tsoutsikos, P
    Bowalgaha, K
    Elliot, DJ
    Miners, JO
    DRUG METABOLISM REVIEWS, 2004, 36 : 135 - 135
  • [7] Involvement of human hepatic UGT1A1, UGT2B4, and UGT2B7 in the glucuronidation of carvedilol
    Ohno, A
    Saito, Y
    Hanioka, N
    Jinno, H
    Saeki, M
    Ando, M
    Ozawa, S
    Sawada, J
    DRUG METABOLISM AND DISPOSITION, 2004, 32 (02) : 235 - 239
  • [8] GLUCURONIDATION OF CLOPIDOGREL BY HUMAN UGT ENZYMES: MAJOR CONTRIBUTIONS BY UGT2B7 AND UGT2B17
    Kahma, Helina
    Filppula, Anne M.
    Neuvonen, Mikko
    Tornio, Aleksi
    Tarkiainen, E. Katriina
    Holmberg, Mikko T.
    Itkonen, Matti K.
    Finel, Moshe
    Neuvonen, Pertti J.
    Niemi, Mikko
    Backman, Janne T.
    DRUG METABOLISM AND PHARMACOKINETICS, 2017, 32 (01) : S36 - S36
  • [9] Role of HNF-1A in the regulation of UGT1A1, UGT1A9 and UGT2B7 MRNA expression.
    Mirkov, S
    Innocenti, F
    Liu, W
    Chen, PX
    Ramirez, J
    Undevia, SD
    Das, S
    Ratain, MJ
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P61 - P61
  • [10] Human UGT2B7 catalyzes morphine glucuronidation
    Coffman, BL
    Rios, GR
    King, CD
    Tephly, TR
    DRUG METABOLISM AND DISPOSITION, 1997, 25 (01) : 1 - 4